Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics, Inc. - Common Stock (NQ:CARA)

4.850 -0.100 (-2.02%)
Streaming Delayed Price Updated: 10:51 AM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
Palo Alto Networks To Join S&P 500 Index: Here Are All The S&P Index Changes
Here are the changes to the S&P indexes before the open on June 20. 
Via Investor's Business Daily
Cara Therapeutics to Present at the Jefferies Healthcare Conference
From Cara Therapeutics, Inc.
Via GlobeNewswire
Marijuana Stock Movers For May 31, 2023
Via Benzinga
Cara Therapeutics: Q1 Earnings Insights
Via Benzinga
7 Stocks With 1,000% Upside Potential
Although most investors should stay away from this list, speculators may appreciate these stocks with massive upside potential. 
Via InvestorPlace
Bearish Monday For Marijuana Stocks - Tilray Brands, HEXO Among Top Gainers
Via Benzinga
Bearish Friday For Marijuana Stocks - Tilray Brands, HEXO Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From May 25, 2023
Via Benzinga
Marijuana Stock Movers For May 24, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 63 companies hit new 52-week lows. 
Via Benzinga
Cannabis Stock Gainers And Losers From May 18, 2023
Via Benzinga
Hero or Zero? 7 Speculative Small-Cap Stocks to Make You Rich… or Broke.
While lesser-known enterprises present viability risks, those wanting to swing for the fences should seek small-cap stocks to buy. 
Via InvestorPlace
Kapruvia® (difelikefalin) recommended by England’s NICE for the treatment of adults with moderate-to-severe CKD-associated pruritus
Recommendation will enable eligible patients in England, Wales and Northern Ireland to access the first licensed treatment for moderate-to-severe chronic kidney disease (CKD)-associated pruritus in... 
From Cara Therapeutics, Inc.
Via GlobeNewswire
Bullish Wednesday For Marijuana Stocks - iAnthus Capital Hldgs, Charlottes Web Holdings Among Top Gainers
Via Benzinga
Cannabis Stock Gainers And Losers From May 16, 2023
Via Benzinga
Cara Therapeutics Revenue Grows 29% To $6.2M
Cara Therapeutics, Inc. (NASDAQ: CARA) released its financial results for the first quarter ended March 31, 2023, revealing revenues of $6.2 million, an increase of 29% compared to $4.8 million in Q1... 
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 15, 2023
Via Benzinga
Cara Therapeutics Reports First Quarter 2023 Financial Results
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Movers For May 4, 2023
Via Benzinga
Marijuana Stock Movers For May 2, 2023
Via Benzinga
Cara Therapeutics to Announce First Quarter 2023 Financial Results on May 15, 2023
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From April 28, 2023
Via Benzinga
Cannabis Stock Movers For April 20, 2023
Via Benzinga
Cannabis Stock Movers For April 18, 2023
Via Benzinga
Cannabis Stock Movers For April 17, 2023
Via Benzinga
Cannabis Stock Movers For April 14, 2023
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 13, 2023
Via Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Cannabis Stock Gainers And Losers From April 12, 2023
Via Benzinga
Cannabis Stock Gainers And Losers From April 11, 2023
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.